Sales/Maturities of Investments

$7.07B

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$7.07Bperiod endingJun 30, 2026

VRTX TTM Sales/Maturities of Investments ($0.00 → $7.07B)

TTM Sales/Maturities of Investments

High-resolution chart · PNG

VRTX sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period ending	Sales/Maturities of Investments (USD)
Jun 30, 2001	1,398,914,000
Mar 31, 2001	1,219,812,000
Dec 31, 2000	1,088,582,000
Sep 30, 2000	290,677,000
Jun 30, 2000	283,697,000
Mar 31, 2000	325,938,000
Dec 31, 1999	428,900,000
Sep 30, 1999	838,700,000
Jun 30, 1999	762,100,000
Mar 31, 1999	661,700,000
Dec 31, 1998	495,500,000
Sep 30, 1998	700,000
Jun 30, 1998	700,000
Mar 31, 1998	700,000
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	5,800,000
Dec 31, 1996	7,100,000
Sep 30, 1996	7,100,000
Jun 30, 1996	7,100,000
Mar 31, 1996	1,300,000
Dec 31, 1995	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	2,600,000
Jun 30, 1994	2,600,000
Mar 31, 1994	2,600,000
Dec 31, 1993	9,300,000
Sep 30, 1993	6,700,000
Jun 30, 1993	6,700,000
Mar 31, 1993	6,700,000
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0